Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics

Journal of Infectious Diseases

Volumn 199, Issue 2, 2009, Pages 209-218

  Trotonda, María Pilar ^a   Xiong, Yan Q ^b,c,d   Memmi, Guido ^a   Bayer, Arnold S ^b,c   Cheung, Ambrose L ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE; OXACILLIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; AUTOLYSIS; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; ENDOCARDITIS; EXPERIMENTAL MODEL; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MGRA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SARA GENE; SARV GENE; SINGLE DRUG DOSE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIOLYSIS; CELL WALL; COMMUNITY-ACQUIRED INFECTIONS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, BACTERIAL; ENDOCARDITIS, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MUTATION; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; OXACILLIN; RABBITS; STAPHYLOCOCCAL INFECTIONS; TRANS-ACTIVATORS; VANCOMYCIN;

EID: 58849122822     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/595740     Document Type: Article

References (46)

1. Lowy F. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-32.
2. Crossley KB, Archer GL. The staphylococci in human disease. New York, NY: Churchill Livingston, 1997.
3. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40:135-6.
4. Bogdanovich T, Ednie LM, Shapiro S, Appelbaum PC. Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother 2005; 49:4210-9.
5. Jones T, Yeaman MR, Sakoulas G, et al. Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother 2008; 52:269-78.
6. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 2003; 48:1429-49.
7. Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong YQ. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol 2004; 40:1-9.
8. Arvidson S, Tegmark K. Regulation of virulence determinants in Staphylococcus aureus. Int J Med Microbiol 2001; 291:159-70.
9. Pragman AA, Yarwood JM, Tripp TJ, Schlievert PM. Characterization of virulence factor regulation by SrrAB, a two-component system in Staphylococcus aureus. J Bacteriol 2004; 186:2430-8.
10. Ingavale S, van Wamel W, Luong TT, Lee CY, Cheung AL. Rat/MgrA, a regulator of autolysis, is a regulator of virulence genes in Staphylococcus aureus. Infect Immun 2005; 73:1423-31.
11. Fournier B, Hooper DC. A new two-component regulatory system involved in adhesion, autolysis and extracellular proteolytic activity of Staphylococcus aureus. J Bacteriol 2000; 182:3955-64.
12. Truong-Bolduc QC, Dunman PM, Strahilevitz J, Hooper DC. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J Bacteriol 2005; 187:2395-405.
13. Truong-Bolduc QC, Hooper DC. The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus. J Bacteriol 2007; 189:2996-3005.
14. Manna AC, Ingavale SS, Maloney M, Van Wamel W, Cheung AL. Identification of sarV (SA2062), a new transcriptional regulator, is repressed by SarA and MgrA (SA0641) and involved in the regulation of autolysis in Staphylococcus aureus. J Bacteriol 2004; 186:5267-80.
15. Moreillon P, Markiewicz Z, Nachman S, Tomasz A. Two bactericidal targets for penicillin in pneumococci: autolysis-dependent and autolysis-independent killing mechanisms. Antimicrob Agents Chemother 1990; 34:33-9.
16. Ingavale S, Van Wamel W, Cheung AL. Characterization of RAT, an autolysis regulator in Staphylococcus aureus. Mol Microbiol 2003; 48:1451-66.
17. Schenk S, Laddaga RA. Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol Lett 1992; 73:133-8.
18. Chambers HF, Hartman BJ, Tomasz A. Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin. J Clin Invest 1985; 76:325-31.
19. Fey PD, Said-Salim B, Rupp ME, et al. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:196-203.
20. Robinson DA, Monk AB, Cooper JE, et al. Evolutionary genetics of the accessory gene regulator (agr) locus in Staphylococcus aureus. J Bacteriol 2005; 187:8312-21.
21. Cassat JE, Dunman PM, McAleese F, et al. Comparative genomics of Staphylococcus aureus musculoskeletal isolates. J Bacteriol 2005; 187:576-92.
22. Yarwood JM, McCormick JK, Pausttian ML, et al. Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. J Biol Chem 2002; 277:13138-47.
23. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002; 359:1819-27.
24. Arnaud M, Chastanet A, Debarbouille M. New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl Environ Microbiol 2004; 70:6887-91.
25. Oscarsson J, Tegmark-Wisell K, Arvidson S. Coordinated and differential control of aureolysin (aur) and serine protease (sspA) transcription in Staphylococcus aureus by sarA, rot and agr (RNAIII). Int J Med Microbiol 2006; 296:365-80.
26. Novick RP. Genetic systems in staphylococci. Methods Enzymol 1991; 204:587-636.
27. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning, a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
28. B is essential for biofilm development by Staphylococcus aureus. Mol Microbiol 2003; 48:1075-87.
29. Cheung AL, Eberhardt K, Fischetti VA. A method to isolate RNA from gram-positive bacteria and mycobacteria. Anal Biochem 1994; 222:511-4.
30. Skov R, Frimodt-Moller N, Espersen F. Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagn Microbiol Infect Dis 2001; 40:111-6.
31. Groicher KH, Firek BA, Fujimoto DF, Bayles KW. The Staphylococcus aureus lrgAB operon modulates murein hydrolase activity and penicillin tolerance. J Bacteriol 2000; 182:1794-801.
32. Xiong YQ, Bayer AS, Yeaman MR, van Wamel W, Manna AC, Cheung AL. Impacts of sarA and agr in Staphylococcus aureus strain Newman on fibronectin-binding protein A gene expression and fibronectin adherence capacity in vitro and in experimental infective endocarditis. Infect Immun 2004; 72:1832-6.
33. Hirano L, Bayer AS. β-lactam-β-lactamase inhibitor combinations are active in experimental endocarditis caused by β-lactamase producing, oxacillin-resistant staphylococci. Antimicrob Agents Chemother 1991; 35:685-90.
34. Bayer AS, Lam K. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. J Infect Dis 1985; 151:157-65.
35. Xiong YQ, Willard J, Kadurugamuwa JL, Yu J, Francis KP, Bayer AS. Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis model. Antimicrob Agents Chemother 2005; 49:380-7.
36. Sugai M, Yamada S, Nakashima S, et al. Localized perforation of the cell wall by a major autolysin: atl gene products and the onset of penicillin-induced lysis of Staphylococcus aureus. J Bacteriol 1997; 179:2958-62.
37. Fujimoto DF, Bayles KW. Opposing roles of the Staphylococcus aureus virulence regulators, Agr and Sar, in Triton X-100 and penicillin induced autolysis. J Bacteriol 1998; 180:3724-6.
38. Luong TT, Newell SW, Lee CY. Mgr, a novel global regulator in Staphylococcus aureus. J Bacteriol 2003; 185:3703-10.
39. Brunskill EW, Bayles KW. Identification of LytRS-regulated genes from Staphylococcus aureus. J Bacteriol 1996; 178:5810-2.
40. Rice KC, Mann EE, Endres JL, et al. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci U S A 2007; 104:8113-8.
41. Luong TT, Dunman PM, Murphy E, Projan SJ, Lee CY. Transcription profiling of the mgrA regulon in Staphylococcus aureus. J Bacteriol 2006; 188:1899-910.
42. Bayer AS. Staphylococcal bacteremia and endocarditis. Arch Intern Med 1982; 142:1169.
43. Bayer AS, Norman DC. Valve site-specific pathogenetic differences between right-sided and left-sided bacterial endocarditis. Chest 1990; 98:200-5.
44. Chen PR, Bae T, Williams WA, et al. An oxidation-sensing mechanism is used by the global regulator MgrA in Staphylococcus aureus. Nat Chem Biol 2006; 2:591-5.
45. Liu Y, Manna AC, Pan CH, et al. Structural and function analyses of the global regulatory protein SarA from Staphylococcus aureus. Proc Natl Acad Sci U S A 2006; 103:2392-7.
46. Shakhnovich EA, Hung DT, Pierson E, Lee K, Mekalanos JJ. Virstatin inhibits dimerization of the transcriptional activator ToxT. Proc Natl Acad Sci U S A 2007; 104:2372-7.